The Kidney Research Institute (KRI), a collaboration of Northwest Kidney Centers and UW Medicine, has named Dr. Ian de Boer as its new Director. He becomes only the second director in the KRI’s 14-year history, following the departure of founding Director Dr. Jonathan Himmelfarb. Dr. de Boer has served as Associate Director of the KRI since 2016.
Dr. de Boer is a highly acclaimed researcher, recognized worldwide for his expertise in diabetic kidney disease and vitamin D metabolism, as well as a sought-after research collaborator and speaker. He currently serves as Deputy Editor of the Clinical Journal of the American Society of Nephrology and is co-chair of the international KDIGO Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
In addition to his own research, Dr. de Boer has been an active mentor to many training in Nephrology. He attended medical school at Oregon Health & Science University and completed his residency at the University of California San Francisco, where he was named outstanding third-year medical resident.
Dr. de Boer is an internationally recognized researcher in nephrology, and we are excited to have him leading the KRI,” said Dr. Raj Mehrotra, Head of the University of Washington School of Medicine’s Nephrology Division and Chair of Northwest Kidney Centers Board of Trustees. “He’s well-positioned to ensure the continuity of existing research efforts and to drive exploration and new opportunities for the future.”
The KRI was established in 2008 as a collaboration between UW Medicine and the Northwest Kidney Centers with the mission to conduct research to improve the lives of people with kidney disease. In the years since, the KRI has become recognized worldwide for a wide range of high-impact patient-oriented research, the application of cutting-edge innovative technology, and advances in person-centered care for people living with kidney disease.
